Scilife Pharma Private Limited
Pharmaceutical company · 209 brands · 184 molecules
Ranked #12 of 70 companies in Cardiac Care
Company overview
Scilife Pharma Private Limited is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 209 product registrations across 184 distinct molecules. It is the 69th largest registrant in Pakistan by product count, and ranks 12th of 70 in Cardiac Care. Its portfolio is concentrated in Cardiac Care and Angiotensin-Ii Antagonists, Combinations. It has no DRAP recall, shortage or safety notices on record.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by Scilife
161 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.
Price ceiling age
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
Top molecules by brand count
Therapeutic classes
Conditions treated
Price band (DRAP official ceilings)
Regulatory record
No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Portfolio whitespace
Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.
Get the full profile for Scilife
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included